Biologics represent a breakthrough in the management of airway diseases, offering precision treatments that target specific immune pathways. This special issue, Biologics for Airway Diseases: From ...

Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...

Males hospitalized for chronic obstructive pulmonary disease (COPD) exacerbations face a higher 30-day mortality risk than females, while non-Hispanic Black patients and those identifying as other or ...

Add Yahoo as a preferred source to see more of our stories on Google. Chiesi Group has terminated the development programme for its COPD hopeful Chiesi Group has dropped its late-stage clinical ...

AJMC®: The 2025 update of the GOLD Report (Global Initiative for Chronic Obstructive Lung Disease Global Strategy for Prevention, Diagnosis and Management of COPD) (GOLD 2025) recommends the ...

SERUM thymic stromal lymphopoietin (TSLP) has emerged as a key regulator of Type 2 immune responses, yet its role in adult asthma remains incompletely understood. A recent real-world cohort study in ...

Inhalers that provide fast-acting treatment for people with certain respiratory conditions are contributing to greenhouse gas emissions, which can worsen both climate change and the conditions ...

Asthma inhalers are critical for delivering small amounts of medication to people's lungs to improve breathing and help prevent asthma attacks, but those tiny puffs add up to a large environmental ...

Metered-dose inhaler propellants have contributed a rising amount to greenhouse gases in the U.S. Emissions per inhaler declined slightly over the past decade, but an increase in annual prescription ...

Over 5.6 million people in the U.S. live in a pulmonology desert, according to new research from GoodRx, a platform for medication savings. People who live in these deserts lack adequate access to ...

Unfortunately, asthma and chronic obstructive pulmonary disease (COPD) are both underrecognized and underdiagnosed lung diseases. If they are properly identified, we have many opportunities to improve ...